Candriam Luxembourg S.C.A. reduced its position in Waters Co. (NYSE:WAT) by 6.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,222 shares of the medical instruments supplier’s stock after selling 873 shares during the period. Candriam Luxembourg S.C.A.’s holdings in Waters were worth $2,361,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. LS Investment Advisors LLC lifted its stake in shares of Waters by 7.0% in the 4th quarter. LS Investment Advisors LLC now owns 3,962 shares of the medical instruments supplier’s stock valued at $765,000 after purchasing an additional 259 shares in the last quarter. Chilton Investment Co. LLC lifted its stake in shares of Waters by 6.1% in the 4th quarter. Chilton Investment Co. LLC now owns 4,700 shares of the medical instruments supplier’s stock valued at $908,000 after purchasing an additional 269 shares in the last quarter. Daiwa Securities Group Inc. lifted its stake in shares of Waters by 906.6% in the 4th quarter. Daiwa Securities Group Inc. now owns 39,136 shares of the medical instruments supplier’s stock valued at $7,561,000 after purchasing an additional 35,248 shares in the last quarter. California Public Employees Retirement System lifted its stake in shares of Waters by 2.7% in the 4th quarter. California Public Employees Retirement System now owns 213,631 shares of the medical instruments supplier’s stock valued at $41,271,000 after purchasing an additional 5,663 shares in the last quarter. Finally, Teacher Retirement System of Texas acquired a new position in shares of Waters in the 4th quarter valued at about $6,558,000. 93.36% of the stock is currently owned by institutional investors and hedge funds.
In other Waters news, Director William J. Miller sold 3,500 shares of the company’s stock in a transaction that occurred on Tuesday, December 5th. The stock was sold at an average price of $194.94, for a total value of $682,290.00. Following the transaction, the director now directly owns 25,849 shares of the company’s stock, valued at approximately $5,039,004.06. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Joann A. Reed sold 1,386 shares of the company’s stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $194.07, for a total value of $268,981.02. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 121,289 shares of company stock worth $25,383,542. 5.07% of the stock is currently owned by corporate insiders.
Several equities analysts have recently weighed in on WAT shares. Deutsche Bank lifted their price objective on Waters from $199.00 to $200.00 and gave the company a “hold” rating in a research note on Wednesday, October 25th. Bank of America lifted their price objective on Waters from $192.00 to $202.00 and gave the company a “neutral” rating in a research note on Friday, November 10th. Barclays boosted their price target on Waters from $188.00 to $193.00 and gave the stock an “equal weight” rating in a research report on Wednesday, October 25th. Zacks Investment Research raised Waters from a “hold” rating to a “buy” rating and set a $211.00 price target on the stock in a research report on Monday, October 23rd. Finally, Cowen reissued a “hold” rating and set a $190.00 price target on shares of Waters in a research report on Friday, November 3rd. Twelve research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $203.75.
Waters Co. (WAT) opened at $206.18 on Tuesday. The company has a market capitalization of $16,400.00, a P/E ratio of 1,145.44, a P/E/G ratio of 2.47 and a beta of 0.88. The company has a current ratio of 2.10, a quick ratio of 1.97 and a debt-to-equity ratio of 0.66. Waters Co. has a 52-week low of $152.05 and a 52-week high of $220.20.
Waters (NYSE:WAT) last announced its earnings results on Tuesday, January 23rd. The medical instruments supplier reported $2.51 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.44 by $0.07. Waters had a return on equity of 24.70% and a net margin of 0.88%. The company had revenue of $687.28 million for the quarter, compared to analyst estimates of $671.98 million. During the same period in the prior year, the company posted $2.21 EPS. Waters’s quarterly revenue was up 9.3% on a year-over-year basis. analysts predict that Waters Co. will post 8.16 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: “Waters Co. (WAT) Shares Sold by Candriam Luxembourg S.C.A.” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece of content on another site, it was illegally stolen and reposted in violation of US & international trademark & copyright laws. The original version of this piece of content can be read at https://www.dispatchtribunal.com/2018/02/20/waters-co-wat-shares-sold-by-candriam-luxembourg-s-c-a.html.
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.